ID

38920

Beschrijving

Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2; ODM derived from: https://clinicaltrials.gov/show/NCT01484262

Link

https://clinicaltrials.gov/show/NCT01484262

Trefwoorden

  1. 12-11-19 12-11-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

12 november 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Diabetes NCT01484262

Eligibility Diabetes NCT01484262

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01484262
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
informed consent obtained before any study-related activities. (study-related activities are any procedures related to recording of data according to the protocol)
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
patients willing and able to give signed consent on matching patient data with sick fund data
Beschrijving

Consent Patient data Matching | Sick Fund Data

Datatype

boolean

Alias
UMLS CUI [1,1]
C1511481
UMLS CUI [1,2]
C2707520
UMLS CUI [1,3]
C1708943
UMLS CUI [2,1]
C1411275
UMLS CUI [2,2]
C0016820
UMLS CUI [2,3]
C1511726
patients diagnosed with type 2 diabetes mellitus, currently treated with oral antidiabetic medication, who need treatment intensification with insulin or liraglutide (victoza®) due to inadequate blood glucose control
Beschrijving

Diabetes Mellitus, Non-Insulin-Dependent | Antidiabetics Oral | Patient need for Intensification therapy | Insulin | liraglutide | Victoza | Etiology Blood Glucose Poorly controlled

Datatype

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1527415
UMLS CUI [3,1]
C0686904
UMLS CUI [3,2]
C1511484
UMLS CUI [4]
C0021641
UMLS CUI [5]
C1456408
UMLS CUI [6]
C2732208
UMLS CUI [7,1]
C0015127
UMLS CUI [7,2]
C0005802
UMLS CUI [7,3]
C3853134
patient is a member of the involved sick fund (aok plus)
Beschrijving

Membership Sick Fund

Datatype

boolean

Alias
UMLS CUI [1,1]
C0680038
UMLS CUI [1,2]
C1411275
UMLS CUI [1,3]
C0016820
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
known or suspected contra-indication to the relevant study product according to current spc
Beschrijving

Medical contraindication Investigational New Drugs | Medical contraindication Suspected Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0750491
UMLS CUI [2,3]
C0013230
previous participation in this study
Beschrijving

Study Subject Participation Status

Datatype

boolean

Alias
UMLS CUI [1]
C2348568
history of type 1 diabetes mellitus
Beschrijving

Diabetes Mellitus, Insulin-Dependent

Datatype

boolean

Alias
UMLS CUI [1]
C0011854
previous insulin treatment excluding emergency administration (treatment duration up to a maximum of 3 days)
Beschrijving

Insulin regime Previous | Exception Emergency treatment

Datatype

boolean

Alias
UMLS CUI [1,1]
C0557978
UMLS CUI [1,2]
C0205156
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0013969
previous treatment with liraglutide
Beschrijving

Prior Therapy Liraglutide

Datatype

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C1456408
history of diabetic gastroparesis, diabetic precoma or diabetic ketoacidosis
Beschrijving

Gastroparesis due to diabetes mellitus | Precoma Diabetic | Diabetic Ketoacidosis

Datatype

boolean

Alias
UMLS CUI [1]
C0267176
UMLS CUI [2,1]
C1142529
UMLS CUI [2,2]
C0241863
UMLS CUI [3]
C0011880
progressive fatal disease
Beschrijving

Progressive Disease Fatal

Datatype

boolean

Alias
UMLS CUI [1,1]
C1335499
UMLS CUI [1,2]
C1302234
any reason in judgement of the treating physician that precludes study participation e.g. lack of compliance, safety concerns, alcohol or drug abuse
Beschrijving

Study Subject Participation Status Excluded | Compliance behavior Lacking | Patient safety Concern | Substance Use Disorders

Datatype

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0332196
UMLS CUI [2,1]
C1321605
UMLS CUI [2,2]
C0332268
UMLS CUI [3,1]
C1113679
UMLS CUI [3,2]
C2699424
UMLS CUI [4]
C0038586
patients without legal capacity
Beschrijving

Legal capacity Lacking

Datatype

boolean

Alias
UMLS CUI [1,1]
C0683673
UMLS CUI [1,2]
C0332268

Similar models

Eligibility Diabetes NCT01484262

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01484262
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
informed consent obtained before any study-related activities. (study-related activities are any procedures related to recording of data according to the protocol)
boolean
C0021430 (UMLS CUI [1])
Consent Patient data Matching | Sick Fund Data
Item
patients willing and able to give signed consent on matching patient data with sick fund data
boolean
C1511481 (UMLS CUI [1,1])
C2707520 (UMLS CUI [1,2])
C1708943 (UMLS CUI [1,3])
C1411275 (UMLS CUI [2,1])
C0016820 (UMLS CUI [2,2])
C1511726 (UMLS CUI [2,3])
Diabetes Mellitus, Non-Insulin-Dependent | Antidiabetics Oral | Patient need for Intensification therapy | Insulin | liraglutide | Victoza | Etiology Blood Glucose Poorly controlled
Item
patients diagnosed with type 2 diabetes mellitus, currently treated with oral antidiabetic medication, who need treatment intensification with insulin or liraglutide (victoza®) due to inadequate blood glucose control
boolean
C0011860 (UMLS CUI [1])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0686904 (UMLS CUI [3,1])
C1511484 (UMLS CUI [3,2])
C0021641 (UMLS CUI [4])
C1456408 (UMLS CUI [5])
C2732208 (UMLS CUI [6])
C0015127 (UMLS CUI [7,1])
C0005802 (UMLS CUI [7,2])
C3853134 (UMLS CUI [7,3])
Membership Sick Fund
Item
patient is a member of the involved sick fund (aok plus)
boolean
C0680038 (UMLS CUI [1,1])
C1411275 (UMLS CUI [1,2])
C0016820 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Medical contraindication Investigational New Drugs | Medical contraindication Suspected Investigational New Drugs
Item
known or suspected contra-indication to the relevant study product according to current spc
boolean
C1301624 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])
Study Subject Participation Status
Item
previous participation in this study
boolean
C2348568 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent
Item
history of type 1 diabetes mellitus
boolean
C0011854 (UMLS CUI [1])
Insulin regime Previous | Exception Emergency treatment
Item
previous insulin treatment excluding emergency administration (treatment duration up to a maximum of 3 days)
boolean
C0557978 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0013969 (UMLS CUI [2,2])
Prior Therapy Liraglutide
Item
previous treatment with liraglutide
boolean
C1514463 (UMLS CUI [1,1])
C1456408 (UMLS CUI [1,2])
Gastroparesis due to diabetes mellitus | Precoma Diabetic | Diabetic Ketoacidosis
Item
history of diabetic gastroparesis, diabetic precoma or diabetic ketoacidosis
boolean
C0267176 (UMLS CUI [1])
C1142529 (UMLS CUI [2,1])
C0241863 (UMLS CUI [2,2])
C0011880 (UMLS CUI [3])
Progressive Disease Fatal
Item
progressive fatal disease
boolean
C1335499 (UMLS CUI [1,1])
C1302234 (UMLS CUI [1,2])
Study Subject Participation Status Excluded | Compliance behavior Lacking | Patient safety Concern | Substance Use Disorders
Item
any reason in judgement of the treating physician that precludes study participation e.g. lack of compliance, safety concerns, alcohol or drug abuse
boolean
C2348568 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C1321605 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
C1113679 (UMLS CUI [3,1])
C2699424 (UMLS CUI [3,2])
C0038586 (UMLS CUI [4])
Legal capacity Lacking
Item
patients without legal capacity
boolean
C0683673 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial